Articles in Scholarly Journals [Incomplete List]

1. Platinum Complexes Can Inhibit Matrix Metalloproteinase Activity: Platinum-Diethyl[(methylsulfinyl)methyl]phosphonate Complexes as Inhibitors of Matrix Metalloproteinases 2, 3, 9, and 12
   Journal of Medicinal Chemistry, vol. 50, no. 15, pp. 3434–3441, 2007
2. Journal of Medicinal Chemistry, vol. 49, no. 2, pp. 829–837, 2006
3. Differential processing of antitumour-active and antitumour-inactive trans platinum compounds by SKOV-3 ovarian cancer cells
   Biochemical Pharmacology, vol. 72, no. 3, pp. 280–292, 2006
4. Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance
   Journal of Inorganic Biochemistry, 2006
5. Platinum complexes with imino ethers or cyclic ligands mimicking imino ethers: synthesis, in vitro antitumour activity, and DNA interaction properties
   JBIC Journal of Biological Inorganic Chemistry, vol. 9, no. 6, 2004
6. Endothelial cells in the bone marrow of patients with multiple myeloma
   Blood, vol. 102, no. 9, pp. 3340–3348, 2003
7. Inhibition of endothelial cell functions and of angiogenesis by the metastasis inhibitor NAMI-A
   British Journal of Cancer, vol. 86, no. 6, Article ID 6600176, 5 pages, 2002
8. Current status of trans-platinum compounds in cancer therapy
   Coordination Chemistry Reviews, vol. 216-217, pp. 383–410, 2001
9. Synthesis, crystal structure, spectral properties and cytotoxic activity of platinum(II) complexes of 2-acetyl pyridine and pyridine-2-carbaldehyde N(4)-ethyl-thiosemicarbazones
   Journal of Inorganic Biochemistry, vol. 78, no. 4, pp. 347–354, 2000
10. Antimetastatic properties and DNA interactions of the novel class of dimeric Ru(III) compounds Na2[?trans-RuCl4(Me2SO)?2(µ-L)] (L=ditopic, non-chelating aromatic N-ligand). A preliminary investigation
    Journal of Inorganic Biochemistry, vol. 79, no. 1-4, pp. 173–177, 2000
11. In vitro and in vivo antitumour activity and cellular pharmacological properties of new platinum–iminoether complexes with different configuration at the iminoether ligands
    Journal of Inorganic Biochemistry, vol. 77, no. 1-2, pp. 31–35, 1999
12. Rhodium(III) analogues of antitumour-active ruthenium(III) compounds: The crystal structure of [ImH][-RhCl(Im)] (Im=imidazole)
    Inorganica Chimica Acta, vol. 273, no. 1-2, pp. 62–71, 1998
13. DNA adducts of antitumor trans-[PtCl2 (E-imino ether)2]
    Nucleic Acids Research, vol. 24, no. 2, pp. 336–341, 1996
14. Salivary up-regulation of human polymorphonuclear leucocyte chemotaxis and adhesion-molecule expression
    Archives of Oral Biology, vol. 39, no. 11, pp. 1007–1009, 1994
15. Anti-leukaemic action of RuCl2(DMSO)4 isomers and prevention of brain involvement on P388 leukaemia and on P388/DDP subline
    European Journal of Cancer, vol. 29, no. 13, pp. 1873–1879, 1993
16. Treatment with cyclosporin a does not affect macrophage procoagulant activity and plasminogen activator inhibitor in mice
    Pharmacological Research Communications, vol. 20, no. 4, pp. 255–264, 1988
17. In vitro cisplatin effects on phagocyte functions
    International Journal of Cancer, vol. 35, no. 6, pp. 777–780, 1985